Liu Xudong, Zeng Bingfang, Ma Jie, Wan Chunling
Department of Orthopaedic Surgery, Shanghai Sixth People's Hospital, Shanghai JiaoTong University, Shanghai, China.
Cancer Invest. 2009 Mar;27(3):345-52. doi: 10.1080/07357900802438577.
To identify new biomarkers that facilitate the accurate early diagnosis of osteosarcoma and that may possibly include novel therapeutic candidates, we performed a proteomic approach to compare osteosarcoma cells and human primary cultured osteoblastic cells. Image analysis of silver-stained 2-DE gels revealed that the level of 12 protein spots was significantly different between the two groups of samples (p < .004). After mass spectroscopic identification and database searches, we found that in osteosarcoma cells, the level of HSP70, actin capping protein, ATP synthase, Mthsp75, UQCRC1, Ras-related nuclear protein, UCH-L1, and PRDX4 was elevated. However, the level of pyruvate dehydrogenase E1, Prohibitin, and Annexin V was decreased. Subsequent Western blot analyses of UQCRC1, UCH-L1, and PRDX4 in osteosarcoma tissues confirmed the results obtained by the proteomic analyses. These identified proteins may be potential molecular targets for osteosarcomatous diagnostics and therapeutics.
为了鉴定有助于骨肉瘤准确早期诊断且可能包含新型治疗候选物的新生物标志物,我们采用蛋白质组学方法比较骨肉瘤细胞和人原代培养成骨细胞。对银染二维凝胶进行图像分析发现,两组样品中12个蛋白点的水平存在显著差异(p < 0.004)。经过质谱鉴定和数据库检索,我们发现骨肉瘤细胞中HSP70、肌动蛋白封端蛋白、ATP合酶、Mthsp75、UQCRC1、Ras相关核蛋白、UCH-L1和PRDX4的水平升高。然而,丙酮酸脱氢酶E1、抑制素和膜联蛋白V的水平降低。随后对骨肉瘤组织中UQCRC1、UCH-L1和PRDX4进行的蛋白质印迹分析证实了蛋白质组学分析的结果。这些鉴定出的蛋白质可能是骨肉瘤诊断和治疗的潜在分子靶点。